Preview this article:

There is no abstract available.

Keyword(s): CA-SFM , CLSI , CoNS , EUCAST , MRSE and PBP2a

Article metrics loading...

Loading full text...

Full text loading...



  1. BSAC 2014; Breakpoint tables for interpretation of zone diameters. Version 13. British Society for Antimicrobial Chemotherapy Date last accessed: 29 September 2015 http://bsac.org.uk/susceptibility/methodologylatestversion/
  2. CLSI 2016; Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute;
  3. CA-SFM 2012; Recommendations 2012. Committee for Antibiotic Susceptibility Testing of the French Society of Microbiology. http://www.sfm-microbiologie.org/UserFiles/files/casfm/CASFM_2012.pdf
  4. CA-SFM 2015; Recommendations 2015. Committee for Antibiotic Susceptibility Testing of the French Society of Microbiology. Version 2.0 http://www.sfm-microbiologie.org/UserFiles/files/casfm/CASFM_EUCAST_V1_2015.pdf
  5. Dickinson T. M., Archer G. L. 2000; Phenotypic expression of oxacillin resistance in Staphylococcus epidermidis: roles of mecA transcriptional regulation and resistant-subpopulation selection. Antimicrob Agents Chemother 44:1616–1623[PubMed] [CrossRef]
    [Google Scholar]
  6. EUCAST 2011; Expert rules in antimicrobial susceptibility testing. Version 2. European Committee on Antimicrobial Susceptibility Testing. Date last accessed: 25 February 2016 http://www.eucast.org/expert_rules_and_intrinsic_resistance/
  7. EUCAST 2016; Clinical breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. European Committee on Antimicrobial Susceptibility Testing. Date last accessed: 11 February 2016 http://www.eucast.org/clinical_breakpoints/
  8. Finan J. E., Rosato A. E., Dickinson T. M., Ko D., Archer G. L. 2002; Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression. Antimicrob Agents Chemother 46:24–30[PubMed] [CrossRef]
    [Google Scholar]
  9. Fleer A., Hemels M. A., Paauw A., Krediet T. G. 2012; Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: beta-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin. J Antimicrob Chemother 67:1616–1618 [View Article][PubMed]
    [Google Scholar]
  10. Join-Lambert O. F., Clauser S., Guillet C., Jais J. P., Abachin E., Quesnes G., Carbonnelle E., Le Monnier A., Zahar J. R., Ferroni A. 2007; Comparison of cefoxitin and moxalactam 30 microg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci. J Antimicrob Chemother 59:763–766 [View Article][PubMed]
    [Google Scholar]
  11. Nijjar C. K., Smith M. H., Eltringham I. J. 2014; Adjunctive mecA PCR for routine detection of methicillin susceptibility in clinical isolates of coagulase-negative staphylococci. J Clin Microbiol 52:1678–1681 [View Article][PubMed]
    [Google Scholar]
  12. Pichon B., Hill R., Laurent F., Larsen A. R., Skov R. L., Holmes M., Edwards G. F., Teale C., Kearns A. M. 2012; Development of a real-time quadruplex PCR assay for simultaneous detection of nuc, Panton-Valentine leucocidin (PVL), mecA and homologue mecALGA251. J Antimicrob Chemother 67:2338–2341 [View Article][PubMed]
    [Google Scholar]
  13. Swenson J. M., Tenover F. C. Cefoxitin Disk Study Group 2005; Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J Clin Microbiol 43:3818–3823 [View Article][PubMed]
    [Google Scholar]
  14. Swenson J. M., Brasso W. B., Ferraro M. J., Hardy D. J., Knapp C. C., Lonsway D., McAllister S., Reller L. B., Sader H. S., other authors. 2009; Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp. J Clin Microbiol 47:1902–1905 [View Article][PubMed]
    [Google Scholar]
  15. Trülzsch K., Grabein B., Schumann P., Mellmann A., Antonenka U., Heesemann J., Becker K. 2007; Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens. Int J Syst Evol Microbiol 57:1543–1548 [View Article][PubMed]
    [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error